Brief: BIOSYNEX FY Revenue Up At 34.2 Million Euros
Jan 21 (Reuters) - BIOSYNEX SA ALBIO.PA :
* BIOSYNEX SA 9.7% INCREASE IN 2019 REVENUE TO € 34.2
MILLION
* IN 2020, BIOSYNEX WILL CONTINUE ITS EFFORTS TO DEVELOP ITS
RANGE
OF SELF-TESTS AND PROFESSIONAL TESTS
Source text: https://bit.ly/2G9XaEj
Further company coverage: ALBIO.PA
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Biosynex SA
See all newsBrief: Biosynex FY Revenue Down To EUR 93.1 Million
Brief: Biosynex Announces Completion Of Merger-Absorption Of Theradiag
Brief: Biosynex Q3 Group Revenue Rises To EUR 24.4 Mln
Brief: Biosynex Announces Its Subsidiary Procisedx Acquires Two U.S. Patents
Brief: Biosynex's Procisedx Obtains First FDA Approvals